Naftopidil clinical trials
How each study uses naftopidil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 2 |
| 2014 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 3
Seoul National University Hospital (2) · Dong-A ST Co., Ltd. (1) · Dong-A Pharmaceutical Co., Ltd. (1) · Samsung Medical Center (1) · Apsen Farmaceutica S.A. (1)
Studies
Open first, then newest update. How each study uses naftopidil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTSWithdrawnPhase 3Apsen Farmaceutica S.A.NCT01203371Written as NaftopidilHow we know
- The Effect of Naftopidil for the Double-J Stent DiscomfortCompletedPhase 3Seoul National University HospitalNCT01959074Written as NaftopidilHow we know
- Medical Expulsive Therapy for Ureter Stone Using NaftopidilCompletedPhase 3Seoul National University HospitalNCT01952314Written as Naftopidil 75mgHow we know
- The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male VolunteersCompletedPhase 1Dong-A ST Co., Ltd.NCT00967772Written as NaftopidilHow we know
- Naftopidil 75mg for Improving Clearance of Urinary StonesStatus unknownPhase 4Samsung Medical CenterNCT02011737Written as naftopidil 75mgHow we know
- Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiaCompletedPhase 4Dong-A Pharmaceutical Co., Ltd.NCT01922375Written as NaftopidilHow we know
Codes
What other systems call naftopidil · ClinicalTrials.gg INT003516
- MeSH (NLM) C064357naftopidilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) R9PHW59SFNNAFTOPIDILConfirmed FDA, NLM, Wikidata
- Wikidata Q6958243naftopidilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72927NaftopidilOne source FDA
- DrugBank DB12092One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C064357 | naftopidil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | R9PHW59SFN | NAFTOPIDIL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6958243 | naftopidil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72927 | Naftopidil | One source FDA |
| DrugBank | DB12092 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.